Filing Details
- Accession Number:
- 0000899243-23-007259
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-06 21:09:08
- Reporting Period:
- 2023-03-02
- Accepted Time:
- 2023-03-06 21:09:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1521036 | Lantheus Holdings Inc. | LNTH | In Vitro & In Vivo Diagnostic Substances (2835) | 352318913 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1610676 | Anne Mary Heino | C/O Lantheus Holdings, Inc. 201 Burlington Road, South Bldg Bedford MA 01730 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-03-02 | 76,686 | $0.00 | 749,219 | No | 4 | A | Direct | |
Common Stock | Acquisiton | 2023-03-03 | 74,486 | $0.00 | 823,705 | No | 4 | A | Direct | |
Common Stock | Disposition | 2023-03-03 | 64,658 | $72.90 | 759,047 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-03-03 | 17,397 | $73.35 | 741,650 | No | 4 | S | Direct | |
Common Stock | Disposition | 2023-03-06 | 12,189 | $73.24 | 729,461 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Acquisiton | 2023-03-02 | 44,696 | $0.00 | 44,696 | $73.35 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
44,696 | 2033-03-02 | No | 4 | A | Direct |
Footnotes
- Consists of 25,562 restricted stock units that vest in equal installments over a three-year period and 51,124 Total Shareholder Return performance-based restricted stock units ("PSUs") that cliff vest following a three-year performance period. The amount of PSUs included in this Report reflects the target award, however the ultimate award size can range from 0% to 200% of the target based on the actual performance achieved at the end of the performance period.
- The transaction reported in this Form 4 reflects additional shares of common stock issued by the Company to the reporting person upon the vesting of relative Total Shareholder Return PSUs that were previously granted and included in the Form 4 filed on March 5, 2020. The number of shares reported in the Form 4 reflected 100% of the target number of shares underlying the PSUs. The number of shares that actually vested under the PSUs equaled 200% of the target number of shares. Accordingly, the number of shares reported in this Form 4 reflects the difference between the number of shares that actually vested under the PSUs and the target number of shares originally included in the Form 4.
- The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transaction reported in this Form 4 was effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.14 to $73.135, inclusive. The reporting person undertakes to provide to Lantheus Holdings, Inc. ("LNTH") any security holder of LNTH or the staff of the Securities and Exchange Commission ("SEC"), upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (4) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.14 to $73.99, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (5) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.69 to $72.6, inclusive. The reporting person undertakes to provide to LNTH any security holder of LNTH or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6) to this Form 4.
- The option vests in three equal annual installments beginning on March 2, 2024.